Abstract 15327: The Effect of Rational Emotive Behavior Therapy in Adults With Congenital Heart Disease With Depressive Symptoms
Objective: Some 30 percent of adults with congenital heart disease experience depression. This study aims to show the effectiveness of the rational emotive behavior therapy (REBT) in reducing depression in adult congenital heart disease (ACHD).
Methods: The study was conducted on 36 of ACHD patients showing depressive symptoms who visited a one major cardiac center in Korea between March and December 2011 and agreed to participate in it. The 36 subjects were randomly assigned to experimental and control group of 18 each. The experimental group collectively received a total of eight sessions of the REBT with one session per week lasting two hours per session. And the therapy focused on identifying patients’ unreasonable thoughts and language reflecting them, confirming their irrationality, and refuting them. The effectiveness of the REBT was examined by measuring the Hamilton scale for depression, heart rate variability and salivary cortisol level before the therapy, right after all eight sessions, and four weeks after the therapy.
Results: The average age of the subjects were 43.39 (SD12.14) for the experimental group and 42.26 (SD13.49) for the control group, with 67 percent of the experimental group and 50 percent of the control group female patients. A repeated measures ANOVA showed that the Hamilton scale for depression significantly decreased with time(before, after therapy and 4weeks after therapy) in the experimental group ((F=46.16, p<0.01), and the decrease was larger in the experimental group than in the control group (F=3.95, p<0.05). In terms of heart rate variability, SDNN, RMSSD, TP and HF significantly increased with time in the experimental group (F=89.13, p<0.05), showing increases in autonomic nervous system, and the increase was larger in the experimental group than in the control group (F=5.32, p<0.01). The salivary cortisol level also decreased significantly in the experimental group (F=42.15, p<0.01) and the decrease was larger in the experimental group than in the control group (F=2.32, p<0.05).
Conclusion: The study found that the developed REBT for ACHD is effective in reducing depression among ACHD patients.
- © 2013 by American Heart Association, Inc.